Black Rock Inc. Relay Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,796,210 shares of RLAY stock, worth $63.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,796,210
Previous 9,573,423
2.33%
Holding current value
$63.9 Million
Previous $105 Million
22.86%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RLAY
# of Institutions
188Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$77 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$48.4 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$44.9 Million0.01% of portfolio
-
State Street Corp Boston, MA6.02MShares$39.3 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $784M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...